AngioDynamics to Participate in a Fireside Chat at the Oppenheimer Virtual Healthcare MedTech & Services Conference
07 March 2024 - 8:01AM
Business Wire
AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative
medical technology company focused on restoring healthy blood flow
in the body’s vascular system, expanding cancer treatment options
and improving patient quality of life, today announced that Jim
Clemmer, President and Chief Executive Officer, and Stephen
Trowbridge, Executive Vice President and Chief Financial Officer,
will participate in a fireside chat at the Oppenheimer 34th Annual
Virtual Healthcare MedTech & Services Conference at 12:40 p.m.
ET on Tuesday, March 12, 2024.
A live webcast of the fireside chat will be accessible through
the “Investors” section of the Company’s website at
www.angiodynamics.com and will be available for replay following
the event.
About AngioDynamics, Inc.
AngioDynamics is a leading and transformative medical technology
company focused on restoring healthy blood flow in the body’s
vascular system, expanding cancer treatment options and improving
patient quality of life.
The Company’s innovative technologies and devices are chosen by
talented physicians in fast-growing healthcare markets to treat
unmet patient needs. For more information, visit
www.angiodynamics.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240306337982/en/
Investors: AngioDynamics, Inc. Stephen Trowbridge, Executive
Vice President & CFO (518) 795-1408
AngioDynamics (NASDAQ:ANGO)
Historical Stock Chart
From Mar 2024 to Apr 2024
AngioDynamics (NASDAQ:ANGO)
Historical Stock Chart
From Apr 2023 to Apr 2024